 Daniel Frank
Concepts (780)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Microbiota | 41 | 2024 | 719 | 6.000 |
Why?
| | Gastrointestinal Microbiome | 46 | 2025 | 631 | 5.480 |
Why?
| | Sinusitis | 17 | 2023 | 202 | 4.990 |
Why?
| | Rhinitis | 15 | 2022 | 148 | 4.970 |
Why?
| | Bacteria | 34 | 2023 | 812 | 3.320 |
Why?
| | RNA, Ribosomal, 16S | 49 | 2024 | 519 | 3.310 |
Why?
| | Metagenome | 15 | 2019 | 137 | 3.200 |
Why?
| | Paranasal Sinuses | 10 | 2023 | 74 | 2.430 |
Why?
| | Intestines | 15 | 2022 | 344 | 2.280 |
Why?
| | Dysbiosis | 18 | 2025 | 166 | 2.220 |
Why?
| | Otitis Media | 8 | 2025 | 160 | 2.190 |
Why?
| | Feces | 24 | 2025 | 435 | 1.990 |
Why?
| | RNA, Bacterial | 12 | 2018 | 182 | 1.620 |
Why?
| | Intestinal Mucosa | 19 | 2020 | 575 | 1.620 |
Why?
| | Nasal Polyps | 5 | 2021 | 57 | 1.500 |
Why?
| | Nose | 4 | 2018 | 64 | 1.450 |
Why?
| | Staphylococcus aureus | 6 | 2018 | 434 | 1.380 |
Why?
| | Nasal Cavity | 6 | 2023 | 50 | 1.340 |
Why?
| | Ileum | 5 | 2020 | 115 | 1.250 |
Why?
| | Sequence Analysis, DNA | 17 | 2020 | 771 | 1.240 |
Why?
| | Bacteremia | 6 | 2018 | 192 | 1.230 |
Why?
| | Crohn Disease | 6 | 2020 | 206 | 1.190 |
Why?
| | Phylogeny | 25 | 2020 | 838 | 1.180 |
Why?
| | Gastrointestinal Tract | 7 | 2022 | 182 | 1.100 |
Why?
| | Staphylococcal Infections | 5 | 2018 | 386 | 1.070 |
Why?
| | Chronic Disease | 17 | 2022 | 1690 | 1.020 |
Why?
| | HIV Infections | 15 | 2025 | 2703 | 0.970 |
Why?
| | Nod2 Signaling Adaptor Protein | 4 | 2019 | 33 | 0.910 |
Why?
| | Bacterial Typing Techniques | 4 | 2015 | 42 | 0.900 |
Why?
| | Clostridium Infections | 4 | 2018 | 57 | 0.870 |
Why?
| | Corynebacterium Infections | 3 | 2022 | 40 | 0.850 |
Why?
| | Humans | 134 | 2025 | 128019 | 0.830 |
Why?
| | Nasopharynx | 5 | 2024 | 67 | 0.820 |
Why?
| | Endoribonucleases | 8 | 2002 | 70 | 0.820 |
Why?
| | Biodiversity | 13 | 2020 | 373 | 0.820 |
Why?
| | Bacterial Infections | 3 | 2015 | 232 | 0.790 |
Why?
| | Otitis Media, Suppurative | 1 | 2022 | 4 | 0.790 |
Why?
| | Cholesteatoma | 1 | 2022 | 11 | 0.780 |
Why?
| | Inflammatory Bowel Diseases | 7 | 2018 | 311 | 0.780 |
Why?
| | Inflammation Mediators | 3 | 2023 | 495 | 0.760 |
Why?
| | Breast Feeding | 6 | 2023 | 422 | 0.750 |
Why?
| | RNA, Catalytic | 7 | 2001 | 185 | 0.740 |
Why?
| | Database Management Systems | 2 | 2013 | 48 | 0.730 |
Why?
| | Drinking Water | 1 | 2022 | 74 | 0.710 |
Why?
| | Serine Peptidase Inhibitor Kazal-Type 5 | 1 | 2020 | 3 | 0.700 |
Why?
| | Fatty Acids, Omega-6 | 1 | 2020 | 47 | 0.690 |
Why?
| | User-Computer Interface | 2 | 2013 | 147 | 0.690 |
Why?
| | Inflammation | 12 | 2023 | 2646 | 0.690 |
Why?
| | Proton Pump Inhibitors | 2 | 2018 | 98 | 0.680 |
Why?
| | Male | 67 | 2025 | 62757 | 0.680 |
Why?
| | Molecular Sequence Data | 27 | 2015 | 2820 | 0.670 |
Why?
| | Software | 3 | 2021 | 606 | 0.660 |
Why?
| | Female | 76 | 2025 | 68016 | 0.660 |
Why?
| | Colon | 8 | 2023 | 248 | 0.660 |
Why?
| | Burns | 4 | 2025 | 284 | 0.650 |
Why?
| | Polymerase Chain Reaction | 10 | 2018 | 1020 | 0.640 |
Why?
| | Fatty Acids, Omega-3 | 1 | 2020 | 137 | 0.640 |
Why?
| | Infant Food | 2 | 2025 | 65 | 0.630 |
Why?
| | Esomeprazole | 1 | 2018 | 6 | 0.630 |
Why?
| | Infant Nutritional Physiological Phenomena | 3 | 2025 | 137 | 0.620 |
Why?
| | Colitis, Ulcerative | 3 | 2020 | 113 | 0.610 |
Why?
| | HIV-1 | 8 | 2024 | 833 | 0.610 |
Why?
| | Animals | 54 | 2025 | 34487 | 0.600 |
Why?
| | Sequence Analysis, RNA | 5 | 2020 | 427 | 0.600 |
Why?
| | Iron | 3 | 2017 | 282 | 0.590 |
Why?
| | RNA, Ribosomal | 8 | 2013 | 162 | 0.580 |
Why?
| | Adult | 44 | 2025 | 35176 | 0.580 |
Why?
| | Genes, rRNA | 3 | 2015 | 41 | 0.570 |
Why?
| | Fatty Liver | 2 | 2021 | 231 | 0.560 |
Why?
| | Vagina | 5 | 2016 | 175 | 0.540 |
Why?
| | Middle Aged | 37 | 2025 | 30812 | 0.530 |
Why?
| | Head and Neck Neoplasms | 1 | 2022 | 532 | 0.530 |
Why?
| | Membrane Proteins | 3 | 2021 | 1105 | 0.530 |
Why?
| | Pharynx | 1 | 2016 | 57 | 0.520 |
Why?
| | Nose Diseases | 1 | 2016 | 12 | 0.510 |
Why?
| | Fatigue Syndrome, Chronic | 1 | 2015 | 15 | 0.510 |
Why?
| | Non-alcoholic Fatty Liver Disease | 4 | 2022 | 258 | 0.510 |
Why?
| | Diet | 8 | 2025 | 1198 | 0.510 |
Why?
| | Case-Control Studies | 15 | 2020 | 3324 | 0.510 |
Why?
| | Mice | 28 | 2025 | 16574 | 0.500 |
Why?
| | Biofilms | 5 | 2016 | 242 | 0.490 |
Why?
| | Base Sequence | 18 | 2015 | 2134 | 0.490 |
Why?
| | Delivery, Obstetric | 1 | 2016 | 137 | 0.490 |
Why?
| | Molecular Epidemiology | 1 | 2015 | 63 | 0.470 |
Why?
| | Immunity, Innate | 4 | 2019 | 801 | 0.470 |
Why?
| | Endotoxemia | 2 | 2014 | 82 | 0.470 |
Why?
| | Food | 2 | 2020 | 154 | 0.470 |
Why?
| | Cross-Sectional Studies | 14 | 2023 | 5034 | 0.460 |
Why?
| | Whole Genome Sequencing | 1 | 2015 | 130 | 0.450 |
Why?
| | Hippocampus | 1 | 2018 | 801 | 0.440 |
Why?
| | Gram-Positive Bacteria | 1 | 2013 | 45 | 0.430 |
Why?
| | Genome, Bacterial | 4 | 2016 | 134 | 0.430 |
Why?
| | Escherichia coli Proteins | 5 | 2016 | 177 | 0.430 |
Why?
| | Computer Graphics | 1 | 2013 | 41 | 0.420 |
Why?
| | Lactobacillus | 4 | 2022 | 26 | 0.420 |
Why?
| | Lipid Metabolism | 2 | 2020 | 491 | 0.420 |
Why?
| | Immunity, Mucosal | 4 | 2018 | 94 | 0.410 |
Why?
| | Iron, Dietary | 1 | 2013 | 21 | 0.410 |
Why?
| | Host-Pathogen Interactions | 3 | 2011 | 346 | 0.410 |
Why?
| | Immunoglobulin A | 4 | 2022 | 200 | 0.410 |
Why?
| | Liver | 4 | 2020 | 1826 | 0.400 |
Why?
| | Ear, Middle | 6 | 2025 | 91 | 0.400 |
Why?
| | Bacterial Load | 1 | 2012 | 66 | 0.400 |
Why?
| | Smoking | 2 | 2020 | 1459 | 0.400 |
Why?
| | Methicillin-Resistant Staphylococcus aureus | 1 | 2015 | 215 | 0.400 |
Why?
| | Genitalia, Female | 1 | 2012 | 38 | 0.390 |
Why?
| | Gastrointestinal Diseases | 3 | 2017 | 196 | 0.390 |
Why?
| | Probiotics | 5 | 2018 | 51 | 0.380 |
Why?
| | Diet, High-Fat | 3 | 2019 | 238 | 0.380 |
Why?
| | Mice, Inbred C57BL | 15 | 2025 | 5268 | 0.380 |
Why?
| | Anti-Bacterial Agents | 9 | 2022 | 1689 | 0.370 |
Why?
| | Pregnancy Complications, Infectious | 3 | 2012 | 363 | 0.370 |
Why?
| | Genomics | 4 | 2020 | 714 | 0.360 |
Why?
| | Livestock | 1 | 2010 | 5 | 0.360 |
Why?
| | Obesity | 7 | 2023 | 2859 | 0.350 |
Why?
| | Infectious Disease Transmission, Vertical | 1 | 2012 | 170 | 0.350 |
Why?
| | Ribonucleoproteins, Small Nuclear | 4 | 1995 | 22 | 0.350 |
Why?
| | Asthma | 2 | 2015 | 2212 | 0.340 |
Why?
| | Computational Biology | 3 | 2019 | 595 | 0.340 |
Why?
| | Stress, Psychological | 1 | 2018 | 1060 | 0.340 |
Why?
| | Antibodies, Fungal | 1 | 2010 | 9 | 0.340 |
Why?
| | Escherichia coli | 9 | 2017 | 766 | 0.340 |
Why?
| | Fucosyltransferases | 2 | 2022 | 32 | 0.340 |
Why?
| | DNA Primers | 3 | 2009 | 509 | 0.340 |
Why?
| | Fatty Acids, Volatile | 6 | 2024 | 57 | 0.340 |
Why?
| | Cryptococcus neoformans | 1 | 2010 | 19 | 0.340 |
Why?
| | Bacterial Translocation | 4 | 2019 | 38 | 0.340 |
Why?
| | Weight Loss | 3 | 2021 | 725 | 0.330 |
Why?
| | Agriculture | 1 | 2010 | 92 | 0.330 |
Why?
| | Genome | 2 | 2009 | 277 | 0.330 |
Why?
| | Arthritis, Experimental | 2 | 2023 | 128 | 0.330 |
Why?
| | Fluoroquinolones | 1 | 2009 | 44 | 0.330 |
Why?
| | Catheterization | 2 | 2009 | 171 | 0.320 |
Why?
| | RNA, Small Nuclear | 3 | 1994 | 35 | 0.310 |
Why?
| | Behavior Therapy | 2 | 2021 | 236 | 0.310 |
Why?
| | Butyrates | 2 | 2021 | 54 | 0.310 |
Why?
| | Wound Infection | 1 | 2009 | 29 | 0.310 |
Why?
| | Corynebacterium | 4 | 2022 | 48 | 0.310 |
Why?
| | Arthritis, Rheumatoid | 3 | 2023 | 1088 | 0.310 |
Why?
| | Mycobacterium avium subsp. paratuberculosis | 1 | 2008 | 2 | 0.300 |
Why?
| | Infant | 16 | 2025 | 8912 | 0.300 |
Why?
| | Lipopolysaccharides | 1 | 2012 | 854 | 0.300 |
Why?
| | Confidentiality | 1 | 2008 | 67 | 0.290 |
Why?
| | Salmon | 2 | 2025 | 22 | 0.290 |
Why?
| | Milk, Human | 4 | 2023 | 149 | 0.290 |
Why?
| | Transcriptome | 5 | 2021 | 879 | 0.290 |
Why?
| | Seafood | 2 | 2025 | 27 | 0.290 |
Why?
| | Intraepithelial Lymphocytes | 2 | 2018 | 14 | 0.290 |
Why?
| | Polycystic Ovary Syndrome | 2 | 2021 | 163 | 0.290 |
Why?
| | Pedigree | 4 | 2025 | 485 | 0.290 |
Why?
| | DNA, Bacterial | 6 | 2017 | 323 | 0.290 |
Why?
| | Video Recording | 1 | 2008 | 161 | 0.290 |
Why?
| | Eukaryotic Cells | 3 | 2007 | 34 | 0.280 |
Why?
| | Pneumonia | 2 | 2025 | 600 | 0.280 |
Why?
| | Disease Models, Animal | 7 | 2025 | 3936 | 0.280 |
Why?
| | Genes, Bacterial | 5 | 2018 | 158 | 0.280 |
Why?
| | Diabetes, Gestational | 2 | 2022 | 308 | 0.280 |
Why?
| | Simian Acquired Immunodeficiency Syndrome | 2 | 2019 | 80 | 0.280 |
Why?
| | Congresses as Topic | 1 | 2008 | 211 | 0.270 |
Why?
| | RNA, Transfer | 3 | 1998 | 130 | 0.270 |
Why?
| | Aged | 16 | 2023 | 21892 | 0.270 |
Why?
| | Homeostasis | 5 | 2020 | 605 | 0.270 |
Why?
| | Perilipin-2 | 2 | 2017 | 36 | 0.260 |
Why?
| | Carrier Proteins | 1 | 2010 | 730 | 0.260 |
Why?
| | Nucleic Acid Conformation | 7 | 2002 | 706 | 0.260 |
Why?
| | Genotype | 4 | 2019 | 1828 | 0.260 |
Why?
| | Anemia, Iron-Deficiency | 2 | 2017 | 57 | 0.260 |
Why?
| | Diabetes Mellitus, Type 1 | 7 | 2017 | 3625 | 0.260 |
Why?
| | DNA, Ribosomal | 7 | 2017 | 82 | 0.260 |
Why?
| | Dietary Supplements | 3 | 2019 | 531 | 0.250 |
Why?
| | Lymphocyte Activation | 4 | 2017 | 1096 | 0.250 |
Why?
| | Public Health | 1 | 2010 | 478 | 0.250 |
Why?
| | Genetic Predisposition to Disease | 3 | 2025 | 2261 | 0.250 |
Why?
| | Neoplasms | 2 | 2018 | 2460 | 0.250 |
Why?
| | RNA Processing, Post-Transcriptional | 2 | 1998 | 87 | 0.250 |
Why?
| | Diet, Western | 3 | 2022 | 79 | 0.250 |
Why?
| | Research | 1 | 2008 | 408 | 0.240 |
Why?
| | Fish Products | 1 | 2025 | 7 | 0.240 |
Why?
| | Mice, Inbred NOD | 4 | 2022 | 586 | 0.240 |
Why?
| | Phenotype | 8 | 2020 | 3039 | 0.240 |
Why?
| | Streptococcus pneumoniae | 2 | 2024 | 158 | 0.230 |
Why?
| | Construction Materials | 2 | 2015 | 13 | 0.230 |
Why?
| | High-Throughput Nucleotide Sequencing | 4 | 2017 | 484 | 0.230 |
Why?
| | Cohort Studies | 7 | 2022 | 5378 | 0.230 |
Why?
| | Autism Spectrum Disorder | 2 | 2023 | 385 | 0.230 |
Why?
| | Bile Acids and Salts | 3 | 2022 | 194 | 0.230 |
Why?
| | Palatine Tonsil | 1 | 2024 | 44 | 0.230 |
Why?
| | Air Microbiology | 2 | 2015 | 40 | 0.220 |
Why?
| | Young Adult | 13 | 2024 | 12281 | 0.220 |
Why?
| | Glycerophospholipids | 1 | 2024 | 32 | 0.220 |
Why?
| | Biomarkers | 9 | 2024 | 3874 | 0.220 |
Why?
| | Infant Formula | 2 | 2023 | 74 | 0.220 |
Why?
| | Pregnancy | 11 | 2025 | 6355 | 0.220 |
Why?
| | Herpesvirus 4, Human | 1 | 2024 | 152 | 0.220 |
Why?
| | Pneumococcal Infections | 1 | 2024 | 110 | 0.210 |
Why?
| | Diet, Mediterranean | 1 | 2023 | 29 | 0.210 |
Why?
| | Epstein-Barr Virus Infections | 1 | 2024 | 93 | 0.210 |
Why?
| | RNA, Fungal | 5 | 2002 | 67 | 0.210 |
Why?
| | Colitis | 3 | 2020 | 240 | 0.210 |
Why?
| | Adolescent | 13 | 2024 | 20158 | 0.210 |
Why?
| | RNA Splicing | 3 | 1995 | 262 | 0.210 |
Why?
| | Ear Canal | 1 | 2003 | 15 | 0.210 |
Why?
| | Alternative Splicing | 1 | 2025 | 216 | 0.200 |
Why?
| | Sepsis | 2 | 2023 | 562 | 0.200 |
Why?
| | Species Specificity | 4 | 2020 | 568 | 0.200 |
Why?
| | Ribonuclease P | 7 | 2001 | 25 | 0.200 |
Why?
| | Gene Ontology | 1 | 2022 | 48 | 0.200 |
Why?
| | Somatic Hypermutation, Immunoglobulin | 1 | 2022 | 19 | 0.200 |
Why?
| | Fungal Proteins | 2 | 2000 | 128 | 0.200 |
Why?
| | Genetic Variation | 4 | 2018 | 933 | 0.200 |
Why?
| | Olfaction Disorders | 1 | 2023 | 60 | 0.200 |
Why?
| | Disease Susceptibility | 3 | 2020 | 331 | 0.200 |
Why?
| | 4-Nitroquinoline-1-oxide | 1 | 2022 | 8 | 0.190 |
Why?
| | Exome | 2 | 2020 | 220 | 0.190 |
Why?
| | Mycobacterium | 1 | 2023 | 106 | 0.190 |
Why?
| | T-Lymphocytes, Regulatory | 1 | 2025 | 366 | 0.190 |
Why?
| | Child, Preschool | 10 | 2025 | 10378 | 0.190 |
Why?
| | Immunity | 2 | 2014 | 132 | 0.190 |
Why?
| | Anti-Inflammatory Agents | 2 | 2016 | 467 | 0.190 |
Why?
| | Mycobacterium abscessus | 1 | 2023 | 104 | 0.190 |
Why?
| | CD4-Positive T-Lymphocytes | 3 | 2022 | 1043 | 0.190 |
Why?
| | Receptors, Aryl Hydrocarbon | 1 | 2022 | 51 | 0.190 |
Why?
| | Cadherin Related Proteins | 1 | 2021 | 12 | 0.190 |
Why?
| | Haemophilus Infections | 1 | 2022 | 39 | 0.190 |
Why?
| | Receptors, G-Protein-Coupled | 2 | 2022 | 204 | 0.190 |
Why?
| | Child | 12 | 2025 | 20636 | 0.180 |
Why?
| | Diabetes Mellitus, Experimental | 2 | 2012 | 175 | 0.180 |
Why?
| | Genes, Fungal | 4 | 2000 | 50 | 0.180 |
Why?
| | Toxins, Biological | 1 | 2020 | 11 | 0.180 |
Why?
| | Nutritional Status | 2 | 2014 | 326 | 0.180 |
Why?
| | Health | 2 | 2012 | 73 | 0.180 |
Why?
| | Sleep Apnea, Obstructive | 1 | 2024 | 238 | 0.180 |
Why?
| | Ascomycota | 1 | 2000 | 31 | 0.180 |
Why?
| | Ear, External | 1 | 2020 | 24 | 0.170 |
Why?
| | Plasminogen | 1 | 2020 | 31 | 0.170 |
Why?
| | Saccharomyces cerevisiae | 5 | 2002 | 524 | 0.170 |
Why?
| | Islets of Langerhans | 3 | 2015 | 790 | 0.170 |
Why?
| | Aged, 80 and over | 6 | 2021 | 7029 | 0.170 |
Why?
| | Firmicutes | 2 | 2021 | 18 | 0.170 |
Why?
| | Sevelamer | 1 | 2020 | 9 | 0.170 |
Why?
| | Mice, Nude | 1 | 2022 | 675 | 0.170 |
Why?
| | Carcinogenesis | 1 | 2022 | 209 | 0.170 |
Why?
| | Mouth | 1 | 2020 | 80 | 0.170 |
Why?
| | Mucin 5AC | 1 | 2020 | 69 | 0.170 |
Why?
| | Mice, Knockout | 5 | 2022 | 2757 | 0.170 |
Why?
| | Body Mass Index | 5 | 2020 | 2260 | 0.170 |
Why?
| | Pore Forming Cytotoxic Proteins | 1 | 2020 | 16 | 0.170 |
Why?
| | Dietary Approaches To Stop Hypertension | 1 | 2020 | 12 | 0.170 |
Why?
| | Weight Reduction Programs | 1 | 2021 | 111 | 0.160 |
Why?
| | Vascular Remodeling | 1 | 2021 | 181 | 0.160 |
Why?
| | Autoimmunity | 3 | 2015 | 860 | 0.160 |
Why?
| | Infant, Newborn | 5 | 2025 | 5688 | 0.160 |
Why?
| | Bacteroides | 1 | 2019 | 19 | 0.160 |
Why?
| | Corrinoids | 1 | 2019 | 7 | 0.160 |
Why?
| | X-Box Binding Protein 1 | 1 | 2019 | 9 | 0.160 |
Why?
| | Chemoreceptor Cells | 1 | 2019 | 53 | 0.160 |
Why?
| | Tobacco Smoke Pollution | 1 | 2022 | 229 | 0.160 |
Why?
| | Vitamin B Complex | 1 | 2019 | 41 | 0.160 |
Why?
| | Maternal Nutritional Physiological Phenomena | 1 | 2020 | 169 | 0.150 |
Why?
| | Oxonic Acid | 1 | 2018 | 5 | 0.150 |
Why?
| | Restraint, Physical | 1 | 2018 | 67 | 0.150 |
Why?
| | Polymorphism, Single Nucleotide | 4 | 2020 | 2059 | 0.150 |
Why?
| | Mycobacterium Infections, Nontuberculous | 1 | 2023 | 348 | 0.150 |
Why?
| | Mutation, Missense | 1 | 2020 | 315 | 0.150 |
Why?
| | Cardiovascular Diseases | 3 | 2023 | 1994 | 0.150 |
Why?
| | Organic Chemicals | 1 | 2020 | 128 | 0.150 |
Why?
| | Rats | 8 | 2023 | 5199 | 0.150 |
Why?
| | Hyperuricemia | 1 | 2018 | 44 | 0.150 |
Why?
| | Vitamin B 12 | 1 | 2019 | 122 | 0.150 |
Why?
| | Microbiological Techniques | 2 | 2016 | 30 | 0.150 |
Why?
| | Corrosion | 2 | 2015 | 15 | 0.150 |
Why?
| | Digestive System Surgical Procedures | 1 | 2019 | 96 | 0.150 |
Why?
| | Colony Count, Microbial | 3 | 2016 | 114 | 0.150 |
Why?
| | Random Allocation | 1 | 2018 | 342 | 0.150 |
Why?
| | Fecal Microbiota Transplantation | 1 | 2018 | 18 | 0.140 |
Why?
| | Ethanol | 1 | 2022 | 585 | 0.140 |
Why?
| | Evolution, Molecular | 2 | 2018 | 463 | 0.140 |
Why?
| | Immunoglobulin D | 1 | 2017 | 29 | 0.140 |
Why?
| | Bacteroidaceae | 1 | 2017 | 3 | 0.140 |
Why?
| | Lung | 4 | 2022 | 3745 | 0.140 |
Why?
| | Spondylarthritis | 1 | 2018 | 45 | 0.140 |
Why?
| | Citrobacter rodentium | 1 | 2017 | 7 | 0.140 |
Why?
| | Prospective Studies | 4 | 2020 | 7035 | 0.140 |
Why?
| | Meta-Analysis as Topic | 2 | 2008 | 169 | 0.140 |
Why?
| | Alcohol Drinking | 1 | 2024 | 751 | 0.140 |
Why?
| | Respiratory Sounds | 1 | 2018 | 120 | 0.140 |
Why?
| | Bacterial Toxins | 1 | 2018 | 106 | 0.140 |
Why?
| | Birth Weight | 1 | 2020 | 499 | 0.140 |
Why?
| | Enterobacteriaceae Infections | 1 | 2017 | 37 | 0.140 |
Why?
| | Myeloid Differentiation Factor 88 | 2 | 2017 | 95 | 0.140 |
Why?
| | Water Microbiology | 3 | 2016 | 85 | 0.140 |
Why?
| | Parvovirus | 2 | 2017 | 13 | 0.140 |
Why?
| | Ceftriaxone | 1 | 2016 | 19 | 0.130 |
Why?
| | Down Syndrome | 1 | 2023 | 469 | 0.130 |
Why?
| | Metals | 1 | 1997 | 126 | 0.130 |
Why?
| | Metabolome | 1 | 2020 | 319 | 0.130 |
Why?
| | beta-Lactamases | 1 | 2016 | 34 | 0.130 |
Why?
| | Metabolic Syndrome | 1 | 2020 | 338 | 0.130 |
Why?
| | Micronutrients | 1 | 2017 | 88 | 0.130 |
Why?
| | Autoantibodies | 3 | 2022 | 1461 | 0.130 |
Why?
| | Gene Expression | 2 | 2018 | 1454 | 0.130 |
Why?
| | Pelvic Infection | 1 | 2016 | 4 | 0.130 |
Why?
| | Tissue Adhesives | 1 | 2016 | 17 | 0.130 |
Why?
| | Vaccines, Inactivated | 1 | 2016 | 68 | 0.130 |
Why?
| | Oligonucleotide Probes | 3 | 2005 | 50 | 0.130 |
Why?
| | Salmonella Infections | 1 | 2016 | 53 | 0.130 |
Why?
| | Vitamin E | 1 | 2016 | 119 | 0.130 |
Why?
| | RNA, Messenger | 4 | 2018 | 2669 | 0.130 |
Why?
| | Cholesterol | 3 | 2023 | 406 | 0.130 |
Why?
| | Bacillus | 1 | 2015 | 15 | 0.130 |
Why?
| | Binding Sites | 6 | 1998 | 1241 | 0.130 |
Why?
| | Gelatin | 1 | 2016 | 40 | 0.130 |
Why?
| | Symbiosis | 2 | 2017 | 71 | 0.130 |
Why?
| | Vaccines, Attenuated | 1 | 2016 | 125 | 0.130 |
Why?
| | Interleukin-6 | 2 | 2017 | 712 | 0.130 |
Why?
| | Ethmoid Sinus | 1 | 2015 | 7 | 0.130 |
Why?
| | Antibiosis | 1 | 2015 | 9 | 0.130 |
Why?
| | Polymorphism, Genetic | 1 | 2019 | 638 | 0.120 |
Why?
| | Therapeutic Irrigation | 1 | 2016 | 74 | 0.120 |
Why?
| | Streptococcus mitis | 1 | 2015 | 9 | 0.120 |
Why?
| | Hospitalization | 3 | 2018 | 2057 | 0.120 |
Why?
| | Textiles | 1 | 2015 | 22 | 0.120 |
Why?
| | Metagenomics | 2 | 2019 | 154 | 0.120 |
Why?
| | Dietary Fats | 1 | 2017 | 301 | 0.120 |
Why?
| | Thrombophilia | 1 | 2016 | 66 | 0.120 |
Why?
| | Adenomatous Polyposis Coli Protein | 1 | 2015 | 20 | 0.120 |
Why?
| | Rhinitis, Allergic | 1 | 2016 | 38 | 0.120 |
Why?
| | Electrophoresis, Gel, Pulsed-Field | 1 | 2015 | 19 | 0.120 |
Why?
| | Lymph | 1 | 2015 | 32 | 0.120 |
Why?
| | Hysterectomy | 1 | 2016 | 118 | 0.120 |
Why?
| | Catalase | 1 | 2015 | 128 | 0.120 |
Why?
| | Bacterial Physiological Phenomena | 1 | 2016 | 58 | 0.120 |
Why?
| | Graft vs Host Disease | 1 | 2017 | 238 | 0.120 |
Why?
| | Sanitary Engineering | 1 | 2015 | 5 | 0.120 |
Why?
| | Adenomatous Polyposis Coli | 1 | 2015 | 33 | 0.120 |
Why?
| | Thrombin | 1 | 2016 | 143 | 0.120 |
Why?
| | Double-Blind Method | 3 | 2017 | 1852 | 0.120 |
Why?
| | Vaccines, Conjugate | 1 | 2015 | 63 | 0.120 |
Why?
| | Predictive Value of Tests | 2 | 2018 | 1934 | 0.120 |
Why?
| | Health Facilities | 1 | 2015 | 79 | 0.120 |
Why?
| | Rectum | 1 | 2016 | 169 | 0.120 |
Why?
| | Salmonella typhimurium | 1 | 2016 | 176 | 0.120 |
Why?
| | Diet, Fat-Restricted | 1 | 2015 | 80 | 0.120 |
Why?
| | Bacteriology | 1 | 2014 | 3 | 0.120 |
Why?
| | Carrier State | 1 | 2015 | 60 | 0.120 |
Why?
| | Systemic Inflammatory Response Syndrome | 1 | 2015 | 84 | 0.120 |
Why?
| | Influenza A Virus, H1N1 Subtype | 1 | 2016 | 146 | 0.120 |
Why?
| | Leptin | 1 | 2016 | 218 | 0.120 |
Why?
| | Household Articles | 1 | 2014 | 24 | 0.120 |
Why?
| | Humidity | 1 | 2014 | 48 | 0.120 |
Why?
| | Bacterial Adhesion | 1 | 2015 | 91 | 0.120 |
Why?
| | Escherichia coli Infections | 1 | 2015 | 105 | 0.120 |
Why?
| | Siblings | 1 | 2015 | 215 | 0.120 |
Why?
| | Renal Insufficiency, Chronic | 1 | 2020 | 562 | 0.120 |
Why?
| | Antibiotic Prophylaxis | 1 | 2015 | 101 | 0.120 |
Why?
| | Physical Exertion | 1 | 2015 | 207 | 0.120 |
Why?
| | Gentamicins | 1 | 2015 | 52 | 0.120 |
Why?
| | Hypoxia | 1 | 2021 | 1034 | 0.110 |
Why?
| | Diabetes Mellitus | 2 | 2013 | 994 | 0.110 |
Why?
| | Mucous Membrane | 1 | 2015 | 120 | 0.110 |
Why?
| | Bifidobacterium | 3 | 2022 | 21 | 0.110 |
Why?
| | Adiposity | 2 | 2018 | 504 | 0.110 |
Why?
| | Biota | 1 | 2014 | 35 | 0.110 |
Why?
| | Ribonucleoprotein, U5 Small Nuclear | 1 | 1994 | 11 | 0.110 |
Why?
| | Maternal Welfare | 1 | 2014 | 19 | 0.110 |
Why?
| | Pulmonary Disease, Chronic Obstructive | 1 | 2022 | 944 | 0.110 |
Why?
| | Prenatal Exposure Delayed Effects | 1 | 2020 | 563 | 0.110 |
Why?
| | Pneumococcal Vaccines | 1 | 2015 | 140 | 0.110 |
Why?
| | Hydrogen Sulfide | 1 | 2014 | 42 | 0.110 |
Why?
| | Toll-Like Receptor 3 | 1 | 2013 | 26 | 0.110 |
Why?
| | Body Weight | 2 | 2015 | 930 | 0.110 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 3 | 2020 | 940 | 0.110 |
Why?
| | Cecum | 3 | 2020 | 32 | 0.110 |
Why?
| | Prenatal Nutritional Physiological Phenomena | 1 | 2014 | 59 | 0.110 |
Why?
| | Preconception Care | 1 | 2014 | 40 | 0.110 |
Why?
| | Nutrition Assessment | 1 | 2014 | 85 | 0.110 |
Why?
| | Colorectal Neoplasms | 1 | 2021 | 746 | 0.110 |
Why?
| | Shock, Hemorrhagic | 1 | 2015 | 165 | 0.110 |
Why?
| | Cytokines | 4 | 2023 | 1984 | 0.110 |
Why?
| | Railroads | 1 | 2013 | 5 | 0.110 |
Why?
| | Bacteroidetes | 3 | 2021 | 23 | 0.110 |
Why?
| | Soil Microbiology | 1 | 2015 | 205 | 0.100 |
Why?
| | Haemophilus influenzae | 2 | 2025 | 63 | 0.100 |
Why?
| | Pediatric Obesity | 1 | 2020 | 570 | 0.100 |
Why?
| | Antioxidants | 1 | 2016 | 542 | 0.100 |
Why?
| | Gastric Bypass | 1 | 2014 | 107 | 0.100 |
Why?
| | Consensus | 1 | 2016 | 607 | 0.100 |
Why?
| | Zinc Fingers | 1 | 1992 | 43 | 0.100 |
Why?
| | Burkina Faso | 1 | 2012 | 4 | 0.100 |
Why?
| | Paneth Cells | 1 | 2012 | 16 | 0.100 |
Why?
| | Antibodies, Viral | 1 | 2016 | 601 | 0.100 |
Why?
| | Xenobiotics | 1 | 2012 | 29 | 0.100 |
Why?
| | Carbon Dioxide | 1 | 2014 | 258 | 0.100 |
Why?
| | Aerosols | 1 | 2013 | 168 | 0.100 |
Why?
| | Mammary Glands, Human | 1 | 2012 | 64 | 0.100 |
Why?
| | Bacterial Proteins | 1 | 2018 | 823 | 0.090 |
Why?
| | Evidence-Based Medicine | 1 | 2016 | 709 | 0.090 |
Why?
| | Gonadal Steroid Hormones | 1 | 2013 | 129 | 0.090 |
Why?
| | Skin | 1 | 2016 | 711 | 0.090 |
Why?
| | Prenatal Care | 1 | 2014 | 274 | 0.090 |
Why?
| | Adrenal Cortex Hormones | 1 | 2015 | 518 | 0.090 |
Why?
| | Genetics, Medical | 1 | 2011 | 24 | 0.090 |
Why?
| | Morphogenesis | 1 | 2012 | 156 | 0.090 |
Why?
| | Influenza Vaccines | 1 | 2016 | 532 | 0.090 |
Why?
| | Oligonucleotide Array Sequence Analysis | 2 | 2012 | 755 | 0.090 |
Why?
| | Viruses | 1 | 2012 | 99 | 0.090 |
Why?
| | Kidney | 1 | 2018 | 1306 | 0.090 |
Why?
| | Lactation | 1 | 2012 | 170 | 0.090 |
Why?
| | Testosterone | 1 | 2014 | 369 | 0.090 |
Why?
| | Obesity, Morbid | 1 | 2014 | 239 | 0.090 |
Why?
| | Nutritive Value | 1 | 2010 | 36 | 0.090 |
Why?
| | Food Safety | 1 | 2010 | 18 | 0.090 |
Why?
| | Autophagy-Related Proteins | 1 | 2010 | 41 | 0.090 |
Why?
| | Insulin | 2 | 2022 | 2316 | 0.090 |
Why?
| | Hypertension, Pulmonary | 1 | 2021 | 1747 | 0.090 |
Why?
| | Amphotericin B | 1 | 2010 | 29 | 0.080 |
Why?
| | Bacterial Capsules | 1 | 2010 | 28 | 0.080 |
Why?
| | Risk Factors | 4 | 2018 | 9696 | 0.080 |
Why?
| | Treatment Outcome | 5 | 2018 | 10110 | 0.080 |
Why?
| | Antibodies, Monoclonal | 2 | 2022 | 1354 | 0.080 |
Why?
| | Meningitis, Cryptococcal | 1 | 2010 | 29 | 0.080 |
Why?
| | Urinary Catheterization | 1 | 2009 | 24 | 0.080 |
Why?
| | Dextran Sulfate | 2 | 2020 | 76 | 0.080 |
Why?
| | Cluster Analysis | 3 | 2017 | 477 | 0.080 |
Why?
| | Staphylococcus epidermidis | 1 | 2010 | 75 | 0.080 |
Why?
| | Retrospective Studies | 4 | 2022 | 14404 | 0.080 |
Why?
| | Fatty Acids | 3 | 2022 | 415 | 0.080 |
Why?
| | Catheters, Indwelling | 1 | 2009 | 76 | 0.080 |
Why?
| | Prevalence | 2 | 2014 | 2541 | 0.080 |
Why?
| | Montana | 1 | 2009 | 18 | 0.080 |
Why?
| | Mississippi | 1 | 2009 | 21 | 0.080 |
Why?
| | Prostatectomy | 1 | 2009 | 106 | 0.080 |
Why?
| | Biomass | 1 | 2009 | 126 | 0.080 |
Why?
| | Sequence Alignment | 3 | 2001 | 329 | 0.080 |
Why?
| | CD8-Positive T-Lymphocytes | 1 | 2015 | 840 | 0.080 |
Why?
| | Models, Statistical | 1 | 2013 | 621 | 0.080 |
Why?
| | Flow Cytometry | 3 | 2017 | 1140 | 0.080 |
Why?
| | Permeability | 2 | 2022 | 156 | 0.080 |
Why?
| | Oligodeoxyribonucleotides | 3 | 1994 | 138 | 0.080 |
Why?
| | Rats, Inbred Lew | 3 | 2017 | 92 | 0.080 |
Why?
| | Systems Integration | 1 | 2008 | 39 | 0.080 |
Why?
| | Environment | 1 | 2010 | 342 | 0.080 |
Why?
| | Microscopy, Confocal | 1 | 2009 | 307 | 0.080 |
Why?
| | Housing | 1 | 2009 | 130 | 0.070 |
Why?
| | Diabetes Mellitus, Type 2 | 1 | 2022 | 2428 | 0.070 |
Why?
| | Down-Regulation | 2 | 2024 | 630 | 0.070 |
Why?
| | Gram-Negative Bacteria | 2 | 2004 | 68 | 0.070 |
Why?
| | Longitudinal Studies | 2 | 2018 | 2706 | 0.070 |
Why?
| | Urinary Tract Infections | 1 | 2009 | 144 | 0.070 |
Why?
| | Ecosystem | 2 | 2010 | 563 | 0.070 |
Why?
| | RNA Precursors | 4 | 1998 | 147 | 0.070 |
Why?
| | Prognosis | 2 | 2020 | 3766 | 0.070 |
Why?
| | Gene Expression Regulation | 2 | 2015 | 2508 | 0.070 |
Why?
| | Information Storage and Retrieval | 1 | 2008 | 108 | 0.070 |
Why?
| | Sex Characteristics | 1 | 2013 | 719 | 0.070 |
Why?
| | Geologic Sediments | 1 | 2007 | 41 | 0.070 |
Why?
| | Cross Infection | 1 | 2009 | 199 | 0.070 |
Why?
| | Child Development | 1 | 2012 | 452 | 0.070 |
Why?
| | Plasmids | 4 | 2016 | 354 | 0.070 |
Why?
| | Residence Characteristics | 1 | 2010 | 324 | 0.070 |
Why?
| | Research Personnel | 1 | 2008 | 156 | 0.070 |
Why?
| | Pseudomonas Infections | 1 | 2009 | 218 | 0.070 |
Why?
| | Indomethacin | 1 | 2006 | 77 | 0.070 |
Why?
| | Peptic Ulcer | 1 | 2006 | 18 | 0.070 |
Why?
| | Structure-Activity Relationship | 2 | 2000 | 538 | 0.070 |
Why?
| | Enterococcus faecalis | 1 | 2006 | 27 | 0.070 |
Why?
| | Proteobacteria | 2 | 2017 | 15 | 0.060 |
Why?
| | Common Variable Immunodeficiency | 1 | 2006 | 27 | 0.060 |
Why?
| | Opportunistic Infections | 1 | 2006 | 46 | 0.060 |
Why?
| | Kenya | 2 | 2017 | 107 | 0.060 |
Why?
| | Autoantigens | 2 | 2022 | 416 | 0.060 |
Why?
| | Inpatients | 1 | 2010 | 464 | 0.060 |
Why?
| | Immunoglobulin G | 2 | 2022 | 842 | 0.060 |
Why?
| | Up-Regulation | 2 | 2021 | 822 | 0.060 |
Why?
| | Principal Component Analysis | 2 | 2017 | 182 | 0.060 |
Why?
| | Artificial Intelligence | 1 | 2008 | 244 | 0.060 |
Why?
| | Intestine, Small | 1 | 2006 | 144 | 0.060 |
Why?
| | Clostridium | 2 | 2017 | 14 | 0.060 |
Why?
| | Isomerism | 1 | 2025 | 48 | 0.060 |
Why?
| | Xanthophylls | 1 | 2025 | 18 | 0.060 |
Why?
| | Cystic Fibrosis | 1 | 2015 | 1048 | 0.060 |
Why?
| | Short Bowel Syndrome | 1 | 2005 | 26 | 0.060 |
Why?
| | Food Handling | 1 | 2025 | 59 | 0.060 |
Why?
| | Cloning, Molecular | 3 | 1996 | 522 | 0.060 |
Why?
| | Body Composition | 2 | 2021 | 644 | 0.060 |
Why?
| | Reproducibility of Results | 2 | 2023 | 3009 | 0.060 |
Why?
| | Age Factors | 2 | 2025 | 3100 | 0.060 |
Why?
| | Oropharynx | 1 | 2024 | 42 | 0.060 |
Why?
| | In Situ Hybridization | 1 | 2005 | 291 | 0.060 |
Why?
| | In Situ Hybridization, Fluorescence | 1 | 2005 | 313 | 0.060 |
Why?
| | Mycobacterium avium Complex | 1 | 2005 | 85 | 0.060 |
Why?
| | Gram-Positive Bacterial Infections | 1 | 2005 | 65 | 0.060 |
Why?
| | Mycobacterium avium-intracellulare Infection | 1 | 2005 | 61 | 0.060 |
Why?
| | Comorbidity | 1 | 2009 | 1537 | 0.060 |
Why?
| | Metabolic Networks and Pathways | 2 | 2017 | 175 | 0.060 |
Why?
| | Hydrogen Bonding | 2 | 1994 | 149 | 0.060 |
Why?
| | Continuous Positive Airway Pressure | 1 | 2024 | 69 | 0.050 |
Why?
| | Mycobacterium smegmatis | 1 | 2023 | 11 | 0.050 |
Why?
| | Bites and Stings | 1 | 2004 | 32 | 0.050 |
Why?
| | Cellulitis | 1 | 2004 | 48 | 0.050 |
Why?
| | Zoonoses | 1 | 2004 | 27 | 0.050 |
Why?
| | Blood Pressure | 2 | 2021 | 1711 | 0.050 |
Why?
| | Anti-Inflammatory Agents, Non-Steroidal | 1 | 2006 | 332 | 0.050 |
Why?
| | Tumor Necrosis Factor-alpha | 2 | 2022 | 1185 | 0.050 |
Why?
| | Rats, Sprague-Dawley | 2 | 2021 | 2258 | 0.050 |
Why?
| | Cats | 1 | 2004 | 209 | 0.050 |
Why?
| | Interleukin-17 | 1 | 2023 | 106 | 0.050 |
Why?
| | Hydrogen-Ion Concentration | 2 | 2015 | 541 | 0.050 |
Why?
| | Pilot Projects | 2 | 2018 | 1559 | 0.050 |
Why?
| | Animal Husbandry | 1 | 2023 | 38 | 0.050 |
Why?
| | Gram-Negative Anaerobic Bacteria | 1 | 2002 | 2 | 0.050 |
Why?
| | Respiratory Function Tests | 1 | 2025 | 580 | 0.050 |
Why?
| | Ammonia | 1 | 2023 | 62 | 0.050 |
Why?
| | alpha-Defensins | 1 | 2022 | 10 | 0.050 |
Why?
| | Sanitation | 1 | 2023 | 52 | 0.050 |
Why?
| | Linear Models | 2 | 2016 | 816 | 0.050 |
Why?
| | Housing, Animal | 1 | 2023 | 47 | 0.050 |
Why?
| | Body Surface Area | 1 | 2022 | 33 | 0.050 |
Why?
| | Viral Load | 2 | 2015 | 449 | 0.050 |
Why?
| | Fetal Death | 1 | 2002 | 56 | 0.050 |
Why?
| | Tryptophan | 1 | 2023 | 171 | 0.050 |
Why?
| | Burn Units | 1 | 2022 | 42 | 0.050 |
Why?
| | Chemokines | 1 | 2023 | 221 | 0.050 |
Why?
| | Glycerol | 1 | 2022 | 87 | 0.050 |
Why?
| | Mycobacterium tuberculosis | 1 | 2005 | 307 | 0.050 |
Why?
| | Virulence | 1 | 2023 | 252 | 0.050 |
Why?
| | Amniotic Fluid | 1 | 2002 | 86 | 0.050 |
Why?
| | Algorithms | 1 | 2009 | 1609 | 0.050 |
Why?
| | Smell | 1 | 2023 | 132 | 0.050 |
Why?
| | Japan | 1 | 2021 | 96 | 0.050 |
Why?
| | Mutagenesis, Site-Directed | 2 | 1992 | 358 | 0.050 |
Why?
| | Granzymes | 1 | 2022 | 45 | 0.050 |
Why?
| | Multigene Family | 2 | 2012 | 198 | 0.050 |
Why?
| | Immunity, Humoral | 1 | 2022 | 118 | 0.050 |
Why?
| | Collagen | 1 | 2023 | 429 | 0.050 |
Why?
| | Ligands | 1 | 2023 | 616 | 0.050 |
Why?
| | Bayes Theorem | 1 | 2023 | 369 | 0.050 |
Why?
| | Pigments, Biological | 1 | 2001 | 15 | 0.050 |
Why?
| | Diet, Reducing | 1 | 2021 | 86 | 0.050 |
Why?
| | RNA, Archaeal | 1 | 2001 | 16 | 0.050 |
Why?
| | Systole | 1 | 2021 | 190 | 0.050 |
Why?
| | Waist Circumference | 1 | 2021 | 138 | 0.050 |
Why?
| | Tight Junctions | 1 | 2021 | 74 | 0.040 |
Why?
| | Macrophages | 2 | 2021 | 1460 | 0.040 |
Why?
| | Follow-Up Studies | 3 | 2020 | 4853 | 0.040 |
Why?
| | Aerobiosis | 1 | 2020 | 22 | 0.040 |
Why?
| | Hypertrophy, Right Ventricular | 1 | 2021 | 133 | 0.040 |
Why?
| | Consensus Sequence | 1 | 2000 | 72 | 0.040 |
Why?
| | Microvessels | 1 | 2021 | 79 | 0.040 |
Why?
| | Acetylation | 1 | 2021 | 242 | 0.040 |
Why?
| | DNA, Fungal | 1 | 2000 | 74 | 0.040 |
Why?
| | Cell Culture Techniques | 1 | 2003 | 344 | 0.040 |
Why?
| | Respiratory Tract Infections | 1 | 2024 | 372 | 0.040 |
Why?
| | Interleukin-2 | 1 | 2022 | 434 | 0.040 |
Why?
| | Abortion, Spontaneous | 1 | 2001 | 99 | 0.040 |
Why?
| | Immunohistochemistry | 2 | 2016 | 1663 | 0.040 |
Why?
| | Protective Factors | 1 | 2020 | 91 | 0.040 |
Why?
| | Caloric Restriction | 1 | 2021 | 108 | 0.040 |
Why?
| | Biotransformation | 1 | 2020 | 48 | 0.040 |
Why?
| | Fibrosis | 1 | 2022 | 513 | 0.040 |
Why?
| | Fasting | 1 | 2021 | 264 | 0.040 |
Why?
| | Catalytic Domain | 1 | 2000 | 217 | 0.040 |
Why?
| | Workflow | 1 | 2021 | 154 | 0.040 |
Why?
| | Urinalysis | 1 | 2020 | 69 | 0.040 |
Why?
| | Chemokine CCL2 | 1 | 2020 | 117 | 0.040 |
Why?
| | Time Factors | 1 | 2010 | 6479 | 0.040 |
Why?
| | Glucose Tolerance Test | 1 | 2021 | 356 | 0.040 |
Why?
| | Mutation | 3 | 2021 | 3682 | 0.040 |
Why?
| | Lipids | 1 | 2023 | 619 | 0.040 |
Why?
| | Collagen Type I | 1 | 2020 | 117 | 0.040 |
Why?
| | Spectrometry, Mass, Electrospray Ionization | 1 | 2020 | 167 | 0.040 |
Why?
| | Sequence Homology, Nucleic Acid | 2 | 2002 | 150 | 0.040 |
Why?
| | Catalysis | 2 | 1998 | 305 | 0.040 |
Why?
| | Saliva | 1 | 2020 | 207 | 0.040 |
Why?
| | Substrate Specificity | 2 | 1997 | 366 | 0.040 |
Why?
| | Germ-Free Life | 1 | 2018 | 33 | 0.040 |
Why?
| | Dietary Proteins | 1 | 2020 | 128 | 0.040 |
Why?
| | Serine Endopeptidases | 2 | 1989 | 116 | 0.040 |
Why?
| | Cytoprotection | 1 | 2018 | 50 | 0.040 |
Why?
| | RNA, Transfer, Asp | 1 | 1998 | 2 | 0.040 |
Why?
| | COS Cells | 1 | 2018 | 184 | 0.040 |
Why?
| | Collagen Type II | 1 | 2018 | 47 | 0.040 |
Why?
| | Prokaryotic Cells | 1 | 1998 | 4 | 0.040 |
Why?
| | Acute Disease | 2 | 2016 | 961 | 0.040 |
Why?
| | HIV Seropositivity | 1 | 2019 | 119 | 0.040 |
Why?
| | Chromatography, High Pressure Liquid | 1 | 2020 | 488 | 0.040 |
Why?
| | Syndecan-1 | 1 | 2017 | 27 | 0.040 |
Why?
| | Magnesium | 1 | 1998 | 150 | 0.040 |
Why?
| | Cross-Over Studies | 1 | 2020 | 507 | 0.040 |
Why?
| | Powders | 1 | 2017 | 43 | 0.040 |
Why?
| | Pancrelipase | 1 | 2017 | 6 | 0.030 |
Why?
| | Transforming Growth Factor beta | 1 | 2020 | 443 | 0.030 |
Why?
| | Cell Membrane Permeability | 1 | 2017 | 80 | 0.030 |
Why?
| | Plasma Cells | 1 | 2017 | 65 | 0.030 |
Why?
| | Uric Acid | 1 | 2018 | 160 | 0.030 |
Why?
| | Rats, Wistar | 1 | 2018 | 397 | 0.030 |
Why?
| | Glucose | 1 | 2022 | 983 | 0.030 |
Why?
| | Mucus | 1 | 2017 | 75 | 0.030 |
Why?
| | Prophages | 1 | 2016 | 7 | 0.030 |
Why?
| | Mice, Inbred BALB C | 1 | 2020 | 1227 | 0.030 |
Why?
| | Administration, Oral | 1 | 2019 | 766 | 0.030 |
Why?
| | Genetic Complementation Test | 2 | 1995 | 63 | 0.030 |
Why?
| | Hydroxamic Acids | 1 | 2017 | 88 | 0.030 |
Why?
| | Anthropometry | 1 | 2017 | 204 | 0.030 |
Why?
| | Ciprofloxacin | 1 | 2016 | 30 | 0.030 |
Why?
| | Hemagglutination Inhibition Tests | 1 | 2016 | 38 | 0.030 |
Why?
| | Gene Library | 1 | 1996 | 115 | 0.030 |
Why?
| | Lactobacillales | 1 | 2016 | 5 | 0.030 |
Why?
| | Ferritins | 1 | 2016 | 58 | 0.030 |
Why?
| | Gammaproteobacteria | 1 | 2016 | 13 | 0.030 |
Why?
| | Heart Ventricles | 1 | 2021 | 765 | 0.030 |
Why?
| | Zebrafish | 1 | 2000 | 464 | 0.030 |
Why?
| | Hemostasis, Surgical | 1 | 2016 | 19 | 0.030 |
Why?
| | Interleukin-8 | 1 | 2017 | 258 | 0.030 |
Why?
| | Severity of Illness Index | 2 | 2020 | 2703 | 0.030 |
Why?
| | Pyruvate Kinase | 1 | 2016 | 26 | 0.030 |
Why?
| | Rifamycins | 1 | 2016 | 7 | 0.030 |
Why?
| | Immunoglobulin M | 1 | 2017 | 272 | 0.030 |
Why?
| | Endothelial Cells | 1 | 2021 | 700 | 0.030 |
Why?
| | Sulfasalazine | 1 | 2016 | 23 | 0.030 |
Why?
| | Macaca nemestrina | 1 | 2016 | 29 | 0.030 |
Why?
| | HEK293 Cells | 1 | 2018 | 681 | 0.030 |
Why?
| | Enzyme Activation | 1 | 1997 | 796 | 0.030 |
Why?
| | Transplant Recipients | 1 | 2017 | 152 | 0.030 |
Why?
| | Plethysmography | 1 | 2016 | 106 | 0.030 |
Why?
| | Interleukin 1 Receptor Antagonist Protein | 1 | 2017 | 250 | 0.030 |
Why?
| | Equipment Contamination | 1 | 2016 | 54 | 0.030 |
Why?
| | Alarmins | 1 | 2015 | 24 | 0.030 |
Why?
| | Adipose Tissue | 1 | 2019 | 589 | 0.030 |
Why?
| | Treatment Failure | 1 | 2016 | 338 | 0.030 |
Why?
| | North America | 1 | 2016 | 289 | 0.030 |
Why?
| | Mesentery | 1 | 2015 | 47 | 0.030 |
Why?
| | Ruminococcus | 1 | 2015 | 9 | 0.030 |
Why?
| | Prevotella | 1 | 2015 | 14 | 0.030 |
Why?
| | Simian Immunodeficiency Virus | 1 | 2016 | 83 | 0.030 |
Why?
| | Capsule Endoscopes | 1 | 2015 | 7 | 0.030 |
Why?
| | Microbial Sensitivity Tests | 1 | 2016 | 348 | 0.030 |
Why?
| | Antigens, CD1 | 1 | 2015 | 58 | 0.030 |
Why?
| | Leukocyte L1 Antigen Complex | 1 | 2015 | 29 | 0.030 |
Why?
| | Spleen | 1 | 2017 | 507 | 0.030 |
Why?
| | Molecular Typing | 1 | 2014 | 19 | 0.030 |
Why?
| | Verrucomicrobia | 1 | 2014 | 5 | 0.030 |
Why?
| | Metabolomics | 1 | 2020 | 599 | 0.030 |
Why?
| | Recurrence | 1 | 2018 | 993 | 0.030 |
Why?
| | Tissue Donors | 1 | 2017 | 388 | 0.030 |
Why?
| | Immunoglobulins | 1 | 2015 | 157 | 0.030 |
Why?
| | Bacterial Shedding | 1 | 2014 | 2 | 0.030 |
Why?
| | CD40 Antigens | 1 | 2015 | 88 | 0.030 |
Why?
| | snRNP Core Proteins | 1 | 1994 | 5 | 0.030 |
Why?
| | Lymph Nodes | 1 | 2017 | 465 | 0.030 |
Why?
| | Democratic Republic of the Congo | 1 | 2014 | 25 | 0.030 |
Why?
| | DNA, Recombinant | 1 | 1994 | 46 | 0.030 |
Why?
| | Pakistan | 1 | 2014 | 75 | 0.030 |
Why?
| | Porosity | 1 | 2014 | 94 | 0.030 |
Why?
| | Methane | 1 | 2014 | 49 | 0.030 |
Why?
| | Antibodies, Neutralizing | 1 | 2016 | 263 | 0.030 |
Why?
| | Dose-Response Relationship, Drug | 1 | 2018 | 1943 | 0.030 |
Why?
| | Perioperative Care | 1 | 2015 | 149 | 0.030 |
Why?
| | Toll-Like Receptor 9 | 1 | 2013 | 31 | 0.030 |
Why?
| | Poly I-C | 1 | 2013 | 61 | 0.030 |
Why?
| | Observer Variation | 1 | 2014 | 310 | 0.030 |
Why?
| | Geography | 1 | 2014 | 186 | 0.030 |
Why?
| | Models, Animal | 1 | 2015 | 365 | 0.030 |
Why?
| | Models, Genetic | 2 | 1995 | 591 | 0.030 |
Why?
| | Oncogene Protein v-akt | 1 | 2013 | 24 | 0.030 |
Why?
| | Sequence Deletion | 1 | 1994 | 178 | 0.030 |
Why?
| | CD4 Lymphocyte Count | 1 | 2014 | 267 | 0.030 |
Why?
| | Cell Lineage | 1 | 2015 | 334 | 0.030 |
Why?
| | Mitochondrial Proteins | 1 | 2015 | 245 | 0.030 |
Why?
| | Endoscopy | 1 | 2015 | 266 | 0.030 |
Why?
| | Diarrhea | 1 | 2014 | 178 | 0.030 |
Why?
| | Seasons | 1 | 2015 | 498 | 0.030 |
Why?
| | Mice, Inbred Strains | 1 | 2013 | 402 | 0.030 |
Why?
| | New York City | 1 | 2013 | 80 | 0.030 |
Why?
| | Glycoproteins | 1 | 2015 | 337 | 0.030 |
Why?
| | Genes, Synthetic | 1 | 1992 | 14 | 0.030 |
Why?
| | Genes, Lethal | 1 | 1992 | 29 | 0.030 |
Why?
| | Cell Line | 1 | 2018 | 2736 | 0.030 |
Why?
| | Aging | 1 | 2023 | 1745 | 0.030 |
Why?
| | Trimethoprim | 1 | 2012 | 7 | 0.030 |
Why?
| | Sulfadoxine | 1 | 2012 | 4 | 0.030 |
Why?
| | Peyer's Patches | 1 | 2012 | 7 | 0.030 |
Why?
| | Sulfamethoxazole | 1 | 2012 | 7 | 0.030 |
Why?
| | Staphylococcus | 1 | 2013 | 74 | 0.030 |
Why?
| | Peritonitis | 1 | 2013 | 81 | 0.030 |
Why?
| | Rats, Inbred Strains | 1 | 2012 | 362 | 0.030 |
Why?
| | Liver Cirrhosis | 1 | 2015 | 279 | 0.030 |
Why?
| | Cattle | 2 | 2005 | 962 | 0.020 |
Why?
| | Membrane Glycoproteins | 1 | 2015 | 467 | 0.020 |
Why?
| | Antigens, CD | 1 | 2015 | 481 | 0.020 |
Why?
| | Ribosome Subunits, Small, Eukaryotic | 1 | 2012 | 8 | 0.020 |
Why?
| | Toll-Like Receptors | 1 | 2013 | 179 | 0.020 |
Why?
| | Surgical Wound Infection | 1 | 2015 | 281 | 0.020 |
Why?
| | Real-Time Polymerase Chain Reaction | 1 | 2013 | 323 | 0.020 |
Why?
| | Mothers | 1 | 2018 | 729 | 0.020 |
Why?
| | Multivariate Analysis | 1 | 2016 | 1492 | 0.020 |
Why?
| | Protein Interaction Maps | 1 | 2012 | 40 | 0.020 |
Why?
| | Disease Progression | 1 | 2019 | 2598 | 0.020 |
Why?
| | Oxidative Stress | 1 | 2018 | 1181 | 0.020 |
Why?
| | RNA-Binding Proteins | 1 | 1995 | 388 | 0.020 |
Why?
| | Statistics, Nonparametric | 1 | 2013 | 419 | 0.020 |
Why?
| | Hematopoietic Stem Cell Transplantation | 1 | 2017 | 573 | 0.020 |
Why?
| | Molecular Sequence Annotation | 1 | 2012 | 88 | 0.020 |
Why?
| | Sequence Homology, Amino Acid | 1 | 1992 | 367 | 0.020 |
Why?
| | Saccharomyces cerevisiae Proteins | 1 | 1995 | 377 | 0.020 |
Why?
| | Signal Transduction | 2 | 2015 | 4812 | 0.020 |
Why?
| | Cell Cycle Proteins | 1 | 1995 | 578 | 0.020 |
Why?
| | Interferon-gamma | 1 | 2015 | 760 | 0.020 |
Why?
| | Dendritic Cells | 1 | 2015 | 475 | 0.020 |
Why?
| | Milk | 1 | 2012 | 119 | 0.020 |
Why?
| | Mammary Glands, Animal | 1 | 2012 | 124 | 0.020 |
Why?
| | Drug Combinations | 1 | 2012 | 323 | 0.020 |
Why?
| | T-Lymphocyte Subsets | 1 | 2014 | 409 | 0.020 |
Why?
| | Metabolic Diseases | 1 | 2012 | 104 | 0.020 |
Why?
| | Proto-Oncogene Proteins c-akt | 1 | 2013 | 419 | 0.020 |
Why?
| | Risk Assessment | 2 | 2014 | 3223 | 0.020 |
Why?
| | Hospitals | 1 | 2015 | 631 | 0.020 |
Why?
| | Blood Glucose | 1 | 2021 | 2092 | 0.020 |
Why?
| | Databases, Genetic | 1 | 2012 | 228 | 0.020 |
Why?
| | Gestational Age | 1 | 2014 | 868 | 0.020 |
Why?
| | Blotting, Western | 1 | 2013 | 1169 | 0.020 |
Why?
| | Influenza, Human | 1 | 2016 | 600 | 0.020 |
Why?
| | Quality of Life | 1 | 2022 | 2672 | 0.020 |
Why?
| | Biopsy | 1 | 2014 | 1077 | 0.020 |
Why?
| | Indoles | 1 | 2013 | 371 | 0.020 |
Why?
| | Analysis of Variance | 1 | 2013 | 1266 | 0.020 |
Why?
| | Laparoscopy | 1 | 2014 | 450 | 0.020 |
Why?
| | Animals, Newborn | 1 | 2012 | 801 | 0.020 |
Why?
| | Legionella | 1 | 2009 | 7 | 0.020 |
Why?
| | Gene Regulatory Networks | 1 | 2012 | 279 | 0.020 |
Why?
| | Mycobacterium avium | 1 | 2009 | 21 | 0.020 |
Why?
| | Boronic Acids | 1 | 1989 | 37 | 0.020 |
Why?
| | Enzyme Precursors | 1 | 1989 | 14 | 0.020 |
Why?
| | Microscopy, Electron, Scanning | 1 | 2009 | 195 | 0.020 |
Why?
| | Magnetic Resonance Imaging | 1 | 2021 | 3371 | 0.020 |
Why?
| | Amino Acid Sequence | 1 | 1992 | 2042 | 0.020 |
Why?
| | Gene Expression Profiling | 1 | 2015 | 1681 | 0.020 |
Why?
| | DNA-Binding Proteins | 1 | 1995 | 1421 | 0.020 |
Why?
| | Microscopy, Fluorescence | 1 | 2009 | 399 | 0.020 |
Why?
| | RNA | 1 | 2013 | 881 | 0.020 |
Why?
| | Vaccination | 1 | 2015 | 1343 | 0.020 |
Why?
| | Peptides | 1 | 2012 | 910 | 0.020 |
Why?
| | Enterocolitis, Pseudomembranous | 1 | 2006 | 27 | 0.020 |
Why?
| | Pediatrics | 1 | 2014 | 1044 | 0.020 |
Why?
| | Biomedical Research | 1 | 2012 | 632 | 0.020 |
Why?
| | Amino Acids | 1 | 1989 | 476 | 0.020 |
Why?
| | Cell Proliferation | 1 | 2013 | 2337 | 0.020 |
Why?
| | Guinea Pigs | 1 | 2005 | 156 | 0.020 |
Why?
| | RNA, Ribosomal, 23S | 1 | 2005 | 13 | 0.020 |
Why?
| | Culture Media | 1 | 2005 | 164 | 0.010 |
Why?
| | Postoperative Complications | 1 | 2016 | 2456 | 0.010 |
Why?
| | Tuberculosis, Pulmonary | 1 | 2005 | 135 | 0.010 |
Why?
| | Organ Specificity | 1 | 2005 | 290 | 0.010 |
Why?
| | Apoptosis | 1 | 2013 | 2425 | 0.010 |
Why?
| | Protein Conformation | 2 | 2002 | 853 | 0.010 |
Why?
| | DNA Transposable Elements | 1 | 2005 | 118 | 0.010 |
Why?
| | Gastrostomy | 1 | 2005 | 110 | 0.010 |
Why?
| | Sputum | 1 | 2005 | 301 | 0.010 |
Why?
| | Pregnancy Trimester, Second | 1 | 2002 | 77 | 0.010 |
Why?
| | Gram-Negative Bacterial Infections | 1 | 2002 | 44 | 0.010 |
Why?
| | Drug Therapy, Combination | 1 | 2005 | 1012 | 0.010 |
Why?
| | Combined Modality Therapy | 1 | 2005 | 1199 | 0.010 |
Why?
| | Sensitivity and Specificity | 1 | 2005 | 1813 | 0.010 |
Why?
| | Pregnancy Complications | 1 | 2003 | 487 | 0.010 |
Why?
| | Cations, Divalent | 1 | 1998 | 54 | 0.010 |
Why?
| | United States | 1 | 2015 | 13785 | 0.010 |
Why?
| | Hydrolysis | 1 | 1998 | 184 | 0.010 |
Why?
| | Bacillus subtilis | 1 | 1998 | 65 | 0.010 |
Why?
| | Suppression, Genetic | 1 | 1995 | 25 | 0.010 |
Why?
| | RNA Splicing Factors | 1 | 1995 | 52 | 0.010 |
Why?
| | Mutagenesis | 1 | 1995 | 181 | 0.010 |
Why?
| | Kinetics | 1 | 1998 | 1617 | 0.010 |
Why?
| | Cells, Cultured | 1 | 2001 | 4006 | 0.010 |
Why?
| | Adenosine Triphosphate | 1 | 1995 | 469 | 0.010 |
Why?
| | Crystallography | 1 | 1989 | 26 | 0.010 |
Why?
| | Chemistry | 1 | 1989 | 43 | 0.010 |
Why?
| | Chemical Phenomena | 1 | 1989 | 81 | 0.010 |
Why?
| | Genes | 1 | 1989 | 226 | 0.000 |
Why?
| | Genetic Vectors | 1 | 1989 | 311 | 0.000 |
Why?
| | Recombinant Proteins | 1 | 1989 | 1286 | 0.000 |
Why?
|
|
Frank's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|